January 4, 2021
Tag: Jonathan Serody
December 31, 2020
United Press International: Study: Modified immunotherapy may work in advanced breast cancer
![Headshot of Jonathan Serody.](https://unclineberger.org/wp-content/uploads/sites/867/2020/12/serody_garden-1-600x400.jpg)
December 31, 2020
Study points the way to boosting immunotherapy effectiveness against breast cancer and other solid tumors
CAR-T therapy has proven effective for some blood cancers. New research by Jonathan S. Serody, MD, and colleagues suggests ways to use it effectively to attack solid tumors.
![Natalie Grover, MD, and Barbara Savoldo, MD](https://unclineberger.org/wp-content/uploads/sites/867/2019/01/Natalie-Grover-and-Barbara-Savoldo-600x400.jpg)
December 3, 2018
Study shows promise for fighting relapsed blood cancer with CAR-T immunotherapy, chemotherapy
At the 60th American Society of Hematology Annual Meeting in San Diego on Monday, UNC Lineberger's Natalie Grover, MD, presented preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.